Discovery of New Pyrrolo[2,3-<i>d</i>]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers

Discovery of New Pyrrolo[2,3-<i>d</i>]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers

In the pursuit of developing more potent and effective targeted kinase inhibitors (TKIs), a series of new compounds, specifically halogenated ‘(<i>E</i>)-4-((7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)-<i>N</i>’-benzylidenebenzohydrazides’, we...

Full description

Bibliographic Details
Main Authors:	AbdulAziz A. Alotaibi, Mohammed M. Alanazi, A. F. M. Motiur Rahman
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Pharmaceuticals
Subjects:	Pyrrolo[2,3-<i>d</i>]pyrimidine apoptosis inducer tyrosine kinase inhibitor multiple kinase inhibitor
Online Access:	https://www.mdpi.com/1424-8247/16/9/1324

Similar Items

Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
by: AbdulAziz A. Alotaibi, et al.
Published: (2023-09-01)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
by: Ashwag S. Alanazi, et al.
Published: (2023-06-01)

Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
by: Sonali Kurup, et al.
Published: (2018-01-01)

Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors
by: Alan Jiang, et al.
Published: (2018-03-01)

Expanding the Diversity at the C-4 Position of Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones to Achieve Biological Activity against ZAP-70
by: Victor Masip, et al.
Published: (2021-12-01)

Concise synthesis of pyrrolo[2,3-d]pyrimidine derivatives via the Cu-catalyzed coupling reaction
by: Leilei Wang, et al.
Published: (2017-01-01)

Novel Bis- and Mono-Pyrrolo[2,3-<i>d</i>]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation
by: Andrea Bistrović Popov, et al.
Published: (2021-06-01)

Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Marwa A. Aziz, et al.
Published: (2016-06-01)

Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Eman Z. Elrazaz, et al.
Published: (2015-12-01)

Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors
by: Bo Yang, et al.
Published: (2023-12-01)

The Inhibitory Mechanism of 7<i>H</i>-Pyrrolo[2,3-d]pyrimidine Derivatives as Inhibitors of P21-Activated Kinase 4 through Molecular Dynamics Simulation
by: Juan Du, et al.
Published: (2023-01-01)

Annellation of Triazole and Tetrazole Systems onto Pyrrolo[2,3-d]pyrimidines: Synthesis of Tetrazolo[1,5-c]-pyrrolo[3,2-e]-pyrimidines and Triazolo[1,5-c]pyrrolo-[3,2-e]pyrimidines as Potential Antibacterial Agents
by: Rina D. Shah, et al.
Published: (2002-07-01)

Design and Synthesis of New Thiophene/Thieno[2,3-<i>d</i>]pyrimidines along with Their Cytotoxic Biological Evaluation as Tyrosine Kinase Inhibitors in Addition to Their Apoptotic and Autophagic Induction
by: Elshaymaa I. Elmongy, et al.
Published: (2021-12-01)

Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-<i>d</i>]pyrimidines Kinase Inhibitors
by: Chiara Greco, et al.
Published: (2020-11-01)

Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors
by: Amany Belal, et al.
Published: (2022-12-01)

Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives
by: Farid M. Sroor, et al.
Published: (2023-08-01)

Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme
by: Federica Poggialini, et al.
Published: (2023-01-01)

Structural and Biological Investigations for a Series of N-5 Substituted Pyrrolo[3,2-<i>d</i>]pyrimidines as Potential Anti-Cancer Therapeutics
by: Brian M. Cawrse, et al.
Published: (2019-07-01)

Novel Tyrosine Kinase Targets in Urothelial Carcinoma
by: Javier Torres-Jiménez, et al.
Published: (2021-01-01)

7-Chloro-3-(4-methylbenzenesulfonyl)pyrrolo[1,2-c]pyrimidine
by: Easha Narayan, et al.
Published: (2020-03-01)

Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors
by: Sofija Jovanović Stojanov, et al.
Published: (2022-09-01)

Functionalized 2,3′-Bipyrroles and Pyrrolo[1,2-<i>c</i>]imidazoles from Acylethynylpyrroles and Tosylmethylisocyanide
by: Maxim D. Gotsko, et al.
Published: (2024-02-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011-12-01)

Indolizines and pyrrolo[1,2-c]pyrimidines decorated with a pyrimidine and a pyridine unit respectively
by: Marcel Mirel Popa, et al.
Published: (2015-06-01)

Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
by: Eun Lee, et al.
Published: (2020-10-01)

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)
by: Jeannig Berrou, et al.
Published: (2022-11-01)

Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
by: Rania S.M. Ismail, et al.
Published: (2016-06-01)

Tyrosine Kinase Receptors in Oncology
by: Jorge Esteban-Villarrubia, et al.
Published: (2020-11-01)

New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors
by: Ana Podolski-Renić, et al.
Published: (2021-10-01)

Isomerization of 5-(2<i>H</i>-Azirin-2-yl)oxazoles: An Atom-Economic Approach to 4<i>H</i>-Pyrrolo[2,3-<i>d</i>]oxazoles
by: Timur O. Zanakhov, et al.
Published: (2021-03-01)

Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis
by: Aamal A. Al-Mutairi, et al.
Published: (2022-02-01)

Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK
by: Michael Forster, et al.
Published: (2020-12-01)

Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors
by: Yan Zhang, et al.
Published: (2017-04-01)

Synthesis and Biological Evaluation of a Fused Structure of Indolizine and Pyrrolo[1,2-<i>c</i>]pyrimidine: Identification of Its Potent Anticancer Activity against Liver Cancer Cells
by: Seonghyeon Nam, et al.
Published: (2022-11-01)

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
by: Manali Tilak, et al.
Published: (2021-02-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
by: Qinlian Jiao, et al.
Published: (2018-02-01)

Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells
by: Ana Kostić, et al.
Published: (2021-06-01)

Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
by: Paula Aldaz, et al.
Published: (2021-11-01)

The Pyrazolo[3,4-<i>d</i>]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts
by: Christin Neuber, et al.
Published: (2020-11-01)

Contributing to Biochemistry and Optoelectronics: Pyrrolo[1′,2′:2,3]imidazo[1,5-<i>a</i>]indoles and Cyclohepta[4,5]pyrrolo[1,2-<i>c</i>]pyrrolo[1,2-<i>a</i>]imidazoles via [3+2] Annulation of Acylethynylcycloalka[<i>b</i>]pyrroles with Δ<sup>1</sup>-Pyrrolines
by: Ludmila A. Oparina, et al.
Published: (2023-02-01)